June 9, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Attention: Ada D. Sarmento
Re: | Moleculin Biotech, Inc. | |
Registration Statement on Form S-3 | ||
Registration No. 333-256627 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Moleculin Biotech, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on June 11, 2021, or as soon thereafter as possible on such date.
Very truly yours, | |||
| Moleculin Biotech, Inc. |
| |
|
|
|
|
|
|
|
|
| By: | /s/ Jonathan Foster |
|
|
| Name: Jonathan Foster |
|
|
| Title: Chief Financial Officer |
|